DCF — PROV SACRED HEART MEDICAL CENTER
Enterprise Value: $-836.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-836.5M
Enterprise Value
$-279.8M
PV of Cash Flows
$-556.7M
PV of Terminal Value
$-896.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $974.2M | $-43.8M | -5.0% | $-85.1M | $-77.3M |
| Year 2 | $1.0B | $-35.1M | -4.0% | $-77.6M | $-64.1M |
| Year 3 | $1.0B | $-25.8M | -3.0% | $-69.6M | $-52.3M |
| Year 4 | $1.1B | $-21.3M | -2.0% | $-66.4M | $-45.3M |
| Year 5 | $1.1B | $-19.2M | -2.0% | $-65.6M | $-40.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-836.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$945.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.050000000264322726
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5